4.5 Article

Development and validation of high-throughput liquid chromatography-tandem mass spectrometric method for simultaneous quantification of Clopidogrel and its metabolite in human plasma

Publisher

ELSEVIER
DOI: 10.1016/j.jchromb.2009.12.026

Keywords

Clopidogrel; Metabolite; HTLC; MS/MS; Human plasma; Validation

Ask authors/readers for more resources

A simple, sensitive and reliable method is described for simultaneous quantification of Clopidogrel and its metabolite in human plasma by using HTLC-MS/MS. The analytical procedure involves on-line coupling of extraction with Cyclone P (50 mm x 0.5 mm 50 mu m) HTLC column by injecting 15 mu L sample and chromatographic separation is performed with Cohesive Propel C18 (5 mu m, 3.0 mm x 50 mm), followed by quantification with mass detector in SRM mode using ESI as an interface. The calibration curves were linear over a concentration range of 0.1-8 ng/mL of Clopidogrel and 70 ng/mL to 6 mu g/mL of its metabolite using 20 mL human plasma per batch. The total run time of analysis was 7.5 min and the lower limits of quantification were 0.1 ng/mL for Clopidogrel and 70 ng/mL for its metabolite. The method validation was carried out in terms of specificity, sensitivity, linearity, precision, accuracy and stability. The validated method was applied in bioavailability and bioequivalence study. (C) 2009 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available